• PDF: Delivered by email usually within 12 to 24 UK business hours.

Savient Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile

Savient Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare Deals and Alliances Profile

Savient Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Savient Pharmaceuticals, Inc. (Savient) is a specialty pharmaceuticals company. It is principally engaged in research, development, manufacture, and marketing of pharmaceutical products. The company is formerly called as Bio-Technology General. It operates principally in the U.S., the U.K. and Israel. The company is headquartered in East Brunswick, New Jersey of the United States.

Global Market Direct's Savient Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.

Scope

  • Provides key company information for business intelligence needs
  • Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
  • Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

  • A quick ""one-stop-shop"" to understand the company.
  • Support sales activities by understanding your customers' businesses.
  • Qualify prospective partners and suppliers.
  • Understand and respond to your competitors' business structure, strategy and prospects through.
  • Understanding the key deals which have shaped the company.
Table Of Contents Table Of Contents 2 List of Tables 3 List of Figures 3 Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4 Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5 Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6 Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 7 Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8 Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details 9 Divestiture - Assets 9 Indevus Acquires Delatestryl From Savient Pharmaceuticals 9 Barr Pharmaceuticals Acquires Rights Of Mircette From Organon And Savient 10 Savient Pharmaceuticals Sells Its Global Biologics Manufacturing Business To Ferring International 11 Divestiture - Company 12 Ferring Acquires Bio-Technology General From Savient Pharmaceuticals 12 Equity Offering 13 Savient Pharmaceuticals Announces Registered Direct Offering Of $31 Million 13 Partnerships 14 Savient Pharmaceuticals Enters Into Agreement With Watson Pharmaceuticals 14 Cytogen Signs An Agreement With Savient Pharmaceuticals 15 Savient Signs Agreement With Ferring Pharmaceuticals 16 Savient Pharmaceuticals Terminates Its Licensing Agreement With Berna Biotech 17 Private Equity 18 Savient Pharmaceuticals Sells Its Stake In Rosemont Pharmaceuticals To Close Brothers Private Equity 18 Savient Pharmaceuticals Sells Its Stake In Omrix Biopharmaceuticals To Catalyst Investments 19 Key Competitors 20 Key Employees 20 Locations And Subsidiaries 21 Head Office 21 Other Locations & Subsidiaries 21 Appendix 22 Methodology 22 About Global Markets Direct 22 Contact Us 22 Disclaimer 22 List of Tables Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4 Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5 Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6 Savient Pharmaceuticals, Inc., Deals By Sector, 2004 to YTD 2009 7 Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8 Indevus Acquires Delatestryl From Savient Pharmaceuticals 9 Barr Pharmaceuticals Acquires Rights Of Mircette From Organon And Savient 10 Savient Pharmaceuticals Sells Its Global Biologics Manufacturing Business To Ferring International 11 Ferring Acquires Bio-Technology General From Savient Pharmaceuticals 12 Savient Pharmaceuticals Announces Registered Direct Offering Of $31 Million 13 Savient Pharmaceuticals Enters Into Agreement With Watson Pharmaceuticals 14 Cytogen Signs An Agreement With Savient Pharmaceuticals 15 Savient Signs Agreement With Ferring Pharmaceuticals 16 Savient Pharmaceuticals Terminates Its Licensing Agreement With Berna Biotech 17 Savient Pharmaceuticals Sells Its Stake In Rosemont Pharmaceuticals To Close Brothers Private Equity 18 Savient Pharmaceuticals Sells Its Stake In Omrix Biopharmaceuticals To Catalyst Investments 19 Savient Pharmaceuticals, Inc., Key Employees 20 Savient Pharmaceuticals, Inc., Other Locations 21 Savient Pharmaceuticals, Inc., Subsidiaries 21 List of Figures Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4 Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 5 Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6 Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 7
+44 20 8816 8548

Ask a question about Savient Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare

Enter the characters you see in the picture below
Captcha